The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhône county

The REVELA13 observatory is a unique epidemiological tool listing the new cases of kidney tumors, bladder tumors and acute leukaemias in the Bouches-du-Rhône county (France). Aim was to exploit for the first time data from this observatory regarding new cases of bladder tumors≥T1 in women from 2012 ...

Full description

Saved in:
Bibliographic Details
Published inProgrès en urologie (Paris) Vol. 28; no. 16; p. 935
Main Authors Martin, T, Mantey, K, Boissier, R, Albert, P, Grisoni, V, Lechevallier, E, Barriol, D, Gravis, G, Pignot, G, Rossi, D, Lorca, J, Rattier, C, Eghazarian, C, Daou, N, Davin, J L, Clément, C, Akiki, A, Pascal, L, Karsenty, G
Format Journal Article
LanguageFrench
Published France 01.12.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The REVELA13 observatory is a unique epidemiological tool listing the new cases of kidney tumors, bladder tumors and acute leukaemias in the Bouches-du-Rhône county (France). Aim was to exploit for the first time data from this observatory regarding new cases of bladder tumors≥T1 in women from 2012 to 2014. This epidemiological study was observational and descriptive. Fifteen non-nominative variables from the REVELA13 database were analyzed in order to describe the clinical and pathological characteristics of the incident cases as well as their spatial and temporal distribution. The incidence rates expressed in new cases per year per 100000 inhabitants were standardized on the world age, calculated with 95 % confidence intervals and compared to national estimates for the same period. Incident bladder tumor cases were recorded in 291 women, corresponding to a standardized incidence on the world age of 3.85 [3.32-4.37] new cases per year per 100,000 population, 54 % higher than the national estimates of 2012 and 2015. Median age of diagnostic was 75.9 years. Sex ratio was 19.41 % (W/M). Tumors were predominantly non-muscle-invasive (52 %), high grade (69 %) and without associated carcinoma in situ (Cis) (49 %). The two most affected territories were Marseille and Aubagne-La Ciotat. The REVELA13 observatory has improved our epidemiological knowledge on female bladder tumors in Bouches-du-Rhône county and highlighted a local over incidence. 3.
ISSN:1166-7087
DOI:10.1016/j.purol.2018.09.004